Why Might Clinical Trials Be Taking Longer To Enroll? A Look At The Causes And Solutions

Life science companies are dependent on clinical research to improve our knowledge of life-altering diseases, develop better diagnostic methods and design new treatments or medical devices to ensure better patient care. While it may sometimes seem that such research proceeds at a dizzying pace – consider the development of COVID-19 vaccines, for example – the unfortunate reality is that researchers often encounter lengthy delivery delays, primarily linked to study enrollment. In fact, 80 percent of global trials do not enroll on time. In some cases these delays turn into terminations, causing frustration as well as financial losses. The industry is rightly seeking ways to overcome enrollment blocks.